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Abstract
Scurvy, or vitamin C deficiency, is rarely presented to a rheumatology clinic. It can mimic several rheumatologic disorders.
Although uncommon, it may present as pseudovasculitis or chronic arthritis. Scurvy still exists today within certain
populations, particularly in patients with neurodevelopmental disabilities, psychiatric illness or unusual dietary habits.
Scurvy presentation to the rheumatologist varies from aches and mild pains to excruciating bone pain or arthritis.
Musculoskeletal and mucocutaneous features of scurvy are often what prompts referrals to pediatric rheumatology
clinics. Unless health care providers inquire about nutritional habits and keep in mind the risk of nutritional deficiency, it
will be easy to miss the diagnosis of scurvy. Rarity of occurrence as compared to other nutritional deficiencies, combined
with a lack of understanding about modern-day risk factors for nutritional deficiency, frequently leads to delayed
recognition of vitamin C deficiency.
We report a case of scurvy in a mentally handicapped Saudi child, who presented with new onset inability to walk
with diffuse swelling and pain in the left leg. Skin examination revealed extensive ecchymoses, hyperkeratosis and
follicular purpura with corkscrew hairs, in addition to gingival swelling with bleeding. Clinical diagnosis of scurvy
was rendered and confirmed by low serum vitamin C level. The patient did extremely well with proper nutritional
support and vitamin C supplementation.
It has been noticed lately that there is increased awareness about scurvy in rheumatology literature. A high index
of suspicion, together with taking a thorough history and physical examination, is required for diagnosis of scurvy
in patient who presents with musculoskeletal symptoms. Nutritional deficiency should also be considered by the
rheumatologist formulating differential diagnosis for musculoskeletal or mucocutaneous complaints in children,
particularly those at risk.
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Background
In the 21st century, the most devastating nutritional prob-
lem for many is not lack of nutrients, but rather excessive
calorie intake leading to obesity and other metabolic syn-
dromes. However, despite modernization among almost
all societies, nutritional deficiencies still occur in certain
populations. Children who suffer neurodevelopmental dis-
abilities, psychiatric illness or those with unusual dietary
habits are prone to vitamin C deficiency.
Scurvy has been known since ancient times but the re-
lation between scurvy and its prevention by citrus fruits
was described for the first time by Sir James Lind on
1753. Subsequently, ascorbic acid was first isolated in
1928 [1].
Vitamin C is an essential exogenous vitamin because
the l-gulonolactone oxidase gene is non-functional so it
prevents coding for the enzyme required to convert glu-
cose into ascorbic acid in humans [2]. Ascorbic acid is
involved in the hydroxylation of collagen, the biosyn-
thesis of carnitine and norepinephrine, the metabolism
of tyrosine, and the amidation of peptide hormones [3].
Hence the clinical presentations of vitamin C deficiency
are directly connected to its various uses by the body.
Vitamin C has a half-life of 10 to 20 days. However,
signs of deficiency generally develop after 1 to 3 months
of inadequate vitamin C intake. Clinical features of vita-
min C deficiency may overlap with systemic diseases such
as rheumatologic, infectious, or hematologic disorders.
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Musculoskeletal and mucocutaneous manifestations in
children with scurvy are numerous, characterized by peri-
follicular petechiae, bruising and ecchymoses, gingival in-
flammation and bleeding, alopecia, and bone pain, skeletal
muscle degeneration, and arthritis [4].
Given the present-day rarity of this disease, the consid-
eration of scurvy as a diagnosis is often overlooked by
physicians, leading to extensive laboratory and radio-
graphic testing and unnecessary delays in diagnosis and
treatment [5].
We report a case of scurvy in a mentally handi-
capped Saudi child who presented with new onset in-
ability to walk with diffuse swelling and pain in the
left leg. The patient’s parents gave their written
consent for publication of this report and use of the
photos in the manuscript.
Case presentation
A 12 year-old boy with global neurodevelopmental delay
was referred to the rheumatology clinic with worsening
musculoskeletal pain and refusal to walk for two months.
He also had skin eruption, restlessness and severe anemia
for five months. The skin eruption started as a purpuric
rash over his lower extremities that never faded away. A
few courses of prednisone resulted in no improvement.
Shortly after the onset of rash, he developed coombs’-
positive hemolytic anemia that required three transfu-
sions of packed red blood cells (PRBCs). Two months
prior to his presentation to the clinic, he began refus-
ing to walk, for which he was seen by a pediatrician
and orthopedic surgeon. Radiographs showed no frac-
ture, so physiotherapy was advised. Physiotherapy was
interrupted by worsening pain and swelling over the
left leg. He was seen by a neurologist after the onset
of his symptoms and was given clonazepam to treat
restlessness.
There was no preceding history of trauma, fever, change
in level of consciousness, or seizures. The patient also pre-
sented with no constitutional symptoms, no bleeding from
body orifices, and no change in bowel habits. Preceding
upper respiratory tract infection (URTI) and gastroenter-
ology or genitourinary symptoms were also absent.
The patient was borne of a twin pregnancy that was
ended at 28 weeks’ gestation. Apgar at 1 and 5 min after
birth was 5 and 6 respectively. He stayed ventilated in
NICU for 2 months, and developed retinopathy of prema-
turity and retinal detachment, subsequently losing vision in
the left eye. He was known to have global developmental
delay with non-revealing neurological or metabolic work
up. The delay had therefore been attributed to complica-
tions of prematurity. Although the family had a normal di-
versified diet, the child was exclusively milk-fed. He was
not able to eat or chew hard food because of bad dental
hygiene. Family history was unremarkable for neurological,
metabolic or bleeding problems.
Initial examination
The patient came to the clinic on a wheelchair and was
pale. Tachycardiac HR was 120 beats/minute, afebrile,
with blood pressure of 113/70 mmHg. He was agitated
but conscious, alert and oriented. His weight was 21.5 kg
(<5th percentile), height was 134.5 cm (25th percentile),
and BMI was11.88 kg/m2 (underweight).
There was hard swelling over the left thigh, which was
mildly tender and diffusely swollen, and the patient re-
fused to ambulate. He maintained 90°flexion contracture
over both knees (Fig. 1a). It was difficult to assess his
motor system because of his pain. Skin examination
revealed extensive ecchymoses, follicular hyperkeratosis
and follicular purpura with corkscrew hairs (white arrow),
and neurotic excoriations (black arrow) (Fig. 1a, b and c).
Gingival swelling and intermittent fragility bleeding were
present (Fig. 1c). Red reflex was absent over the left eye,
normal over right. There were no abnormal findings on
chest, cardiovascular and abdominal examination.
Immediate admission for evaluation was arranged and
he had been evaluated by specialists in areas including
hematology, dermatology, neurology, gastroenterology
and nutrition. Work up revealed very low hemoglobin,
56 g/L, so urgent PRBCs transfusion was given. Platelet
count was 371 × 109 /L and reticulocyte count was 4 %.
Peripheral smear showed moderate anisopoikilocytosis.
His erythrocyte sedimentation rate was 44 mm/hour
(reference range: 0–15 mm/hour) at the initial presenta-
tion. Hemoccult blood was negative. Bleeding disorder
work up including prothrombin time, partial thrombo-
plastin time, international normalized ratio (INR), plate-
let aggregation tests, and factor assay for factors VII,
XIII and IX were normal. C-reactive protein, coagulation
profile, and chemistry including calcium, phosphorus,
and magnesium were also normal. Serum iron level was
2.16 μmol/L (reference range 11.6-31.3), vitamin C level
was 5.7 μmol/L (reference range: 28.4-85.2), 25-OH vita-
min D was 92.2 nmol/L(reference range: 75–250), red
blood cell (RBC) folate was 281 nmol/L (reference range:
362–1616), Vitamin B12 was 468 pmol/L (reference
range: 138–652). Radiographs revealed a questionable
right fibular fracture that was not confirmed on a
technetium 99 m bone scan. Ultrasound revealed a large
intramuscular hematoma of different ages over the left
thigh, measuring 5 × 20 cm in anteroposterior and
craniocaudal diameter respectively.
Ascorbic acid (vitamin C) supplement was initiated at
500 mg twice daily for 3 days, then 300 mg daily for
2 weeks and maintained on100mg daily for 3 months. By
4 weeks, the patient was ambulating freely, and skin
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lesions and gingival swelling improved. Three months
later, he came to the clinic walking.
Hemoglobin was 133 g/L, and albumin 43 g/L. A re-
peat vitamin C level was 75 μmol/L (reference range:
28.4-85.2).
Discussion
Humans lack the ability to synthesize vitamin C, because of
mutation in the gene coding for l-gulonolactone oxidase,
the enzyme required for the biosynthesis of vitamin C [6].
However, vitamin C is an essential micronutrient. Scurvy
occurs as a result of decreased vitamin C consumption or
absorption. The prevalence of scurvy in children is not
known, but certain populations are at risk. The two lar-
gest cohorts of scurvy cases in children have been re-
ported by Noble et al., who presented 23 case studies of
scurvy in children with restricted diets, including chil-
dren with autism, developmental delay, and cerebral
palsy [7], and Ratanachu-Ek et al., who reviewed 28
cases of scurvy in Thai children, almost all of whom
presented with inability to walk. Of the cases reviewed
by RatanachuEk et al., 89 % were supplemented with
ultra heat treated (UHT) milk [8].
The earliest manifestations of scurvy are nonspecific
constitutional symptoms, such as asthenia, anorexia, and
weight loss. Musculoskeletal manifestations may be the
presenting symptoms in scurvy; in 80 % of cases, the
manifestations of scurvy include arthralgia, myalgia,
hemarthrosis, and muscular hematomas [9]. As in our
case, inability to walk is a very common presenting mus-
culoskeletal symptom in children with scurvy [8].
Poorly formed collagen leads to dystrophic or corkscrew
hairs, gingival hyperplasia, and weakened blood vessel
walls, causing bleeding in the skin, joints, and other organs
[10]. Follicular hyperkeratosis and perifollicular hemor-
rhages are also common, particularly over the lower limbs,
as was a prominent feature in our case. Subperiosteal he-
matomas may be palpable as painful swellings over the
distal end of the femur and tibia. Intramuscular hemato-
mas may cause compartment syndrome [9]. Our patient
had large, uncomplicated intramuscular hematoma that
resolved spontaneously.
Laboratory test abnormalities in scurvy are nonspe-
cific; anemia is frequent manifestation. Our patient had
severe hemolytic anemia that required multiple blood
transfusions. In severe cases, anemia can lead to cardiac
hypertrophy and high output heart failure [6].
The causes for anemia in scurvy could be multifactorial,
resulting from blood loss, concomitant vitamin deficien-
cies, and decreased iron absorption [11]. An elevated
erythrocyte sedimentation rate and C-reactive protein
level can be seen in some cases [12]. In our case, the sedi-
mentation rate was mildly elevated, which could cause
confusion with an inflammatory process.
Radiographic changes may include osteonecrosis, osteo-
penia, and cortical thinning with periosteal proliferation.
Many signs have been reported in the literature, such as
the Frankel sign (zone of calcification at the margin of
growth plate), Wimberger sign (calcification around the
epiphysis) and scurvy line (lucency adjacent to metaphy-
seal sclerotic line) [13]. In our case, all of these findings
were absent. We speculate that a good level of vitamin D
halted these changes.
A meticulous history, including dietary history and
physical examination, can help to reach the diagnosis of
scurvy. Usually, work up is not necessary to confirm
diagnosis of scurvy.
Vitamin or mineral deficiencies other than vitamin C
deficiency may accompany scurvy, therefore the prudent
clinician will also check for concomitant micronutrient
deficiencies, testing levels of zinc, iron, folate, and vitamin
B12. In our case, RBC folate and serum iron were low.
Known risk factors for scurvy in children are oral aver-
sions, cerebral palsy, developmental delay, and autism.
Our patient had developmental delay as a result of com-
plicated prematurity.
Scurvy is preventable disease. The daily intake of vita-
min C must be no lower than 10 mg/day and the body
pool no smaller than 350 mg to avoid scurvy [2]. The rec-
ommended daily intake is variable according to the child’s
age [14]. Treatment of scurvy is based on replenishing the
Fig. 1 Patient at presentation. a Knee flexion contractures and ecchymoses, b hyperkeratosis and follicular purpura with corkscrew hairs (white arrow),
c hemorrhagic gingivitis and neurotic excoriations (black arrow)
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level of vitamin C to counteract the symptoms. There is
no established regimen for vitamin C supplementation in
scurvy. Supplementation with 1 g/day of oral vitamin C
for 2 weeks is the usual treatment [9]. However, other reg-
imens have been tried, such as 100 to 200 mg/day for a
longer period [4]. Once vitamin C deficiency has been
treated, prevention and correction of underlying condi-
tions are required in order to prevent recurrence.
Following treatment with vitamin C, spontaneous bleed-
ing, oral symptoms and constitutional symptoms begin to
improve within days, while bony changes and ecchymoses
may take several weeks to resolve [12]. Overall improve-
ment of symptoms after the administration of ascorbic
acid is a confirmatory approach for the diagnosis.
Conclusion
Scurvy can present to rheumatologists with different mani-
festations, which mandates careful assessment of the diet
for each child attending rheumatology clinic. The possibility
of scurvy in modern times should not be overlooked, in
particular among susceptible populations. Coexistence of
other nutrient deficiency is not unusual and, when appro-
priate, screening for such deficiencies should be considered.
Most of the time, musculoskeletal complaints in scurvy are
accompanied by cutaneous manifestations that may guide
the diagnosis. Confirmation of scurvy is made by low serum
ascorbic acid level. However, the most cost effective indica-
tor of disease is simply resolution of the manifestations
following replenishing the level with ascorbic acid supple-
ments. Awareness of vitamin C deficiency in children who
present with musculoskeletal pain to rheumatology clinic is
necessary to avoid invasive and unnecessary investigations
and to preserve medical resources.
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